Gregory Ploussios represents software, Internet, life science, and medical device clients, with an emphasis on intellectual-property transfer and licensing transactions, venture-capital financings, and general corporate representation.
Greg is a co-chair of both the Firm's Startup Practice Group and Helping Innovators Thrive (HIT) program ( hit.edwardswildman.com ), which provides support and affordable access to strategic legal advice for qualifying entrepreneurs and young companies. Greg has extensive experience working with start-up companies and entrepreneurs as they form and grow their businesses, and in advising investors in structuring investments in such companies.
Greg also has extensive experience advising both mature and startup companies on software and technology licensing, development, and service agreements, including SaaS, hosting and cloud agreements; reseller, distribution and OEM agreements; and development and collaboration arrangements and joint ventures.
•Drafted and negotiated a broad range of information technology development, collaboration, distribution, value-added reseller, OEM, and supply agreements, including:
•Developed standard license, SaaS, and professional services agreements for Delphi Technology and other software companies
•Advise PatientsLikeMe on partner service and data license agreements; develop standard forms of partnering agreements
•Advise Houghton Mifflin Harcourt Publishing Company on a variety of software and technology development and services agreements and ePublishing agreements
•License and service agreements for Parametric Technology Corporation (PTC) and The MathWorks
•Represent clients in joint-venture and partnering transactions and in licensing technology from universities
•Represent clients in acquisitions/mergers of technology companies, focusing on intellectual-property and licensing aspects, including use of open source software
•Represent start-up information technology, medical-device, and life science companies in venture-capital financings and general corporate concerns, including the following:
•Represented Charles River Ventures in its Series A financing of a technology startup company.
•Advised GnuBio Inc., a developer of fully integrated droplet-based DNA sequencing technology, as general counsel and in its acquisition by Bio-Rad Laboratories, Inc. in a merger transaction including milestone based contingent payments
•Greg has represented Ampersand and MPM Capital in various fund and portfolio matters
•General counsel to Delphi Technology, a developer, licensor and SaaS provider of its OASIS software solution for medical professional liability insurance carries, which provides processing for claims, new business, renewals, and business intelligence
•U.S. general counsel for U.S. operations to Nlyte Software, a developer and licensor of data center software management solution
•General counsel to Cakewalk, developer of music creation and recording software applications
•General counsel to Digital Paradigms, a developer and provider of bio-informatics and meta-tracking enterprise software solutions
•General counsel to Karen Clark & Company, experts in catastrophe risk, catastrophe models and catastrophe risk management
•General counsel to VoteTru LLC, a developer and provider of an employee voting platform used to power organizational decisions, actions, and growth, and foster superior customer and employee loyalty
Besides Edwards Wildman
Greg programs software as a hobby, and has programmed and sold computer versions of two board games to the owners of the original games.
• South Asia
Rising Star in the area of Intellectual Property by the Massachusetts Super Lawyers publication.
Sale of Cakewalk, Inc.
An Edwards Wildman team represented Cakewalk, Inc., a long-standing client and developer and licensor of music production software (including the SONAR product line), in its recent sale to Gibson Brands, Inc.
PTC Inc. Acquisition of Software Developer
A large team of Edwards Wildman lawyers represented longtime client PTC in its acquisition of Enigma Information Systems Ltd., an Israeli software developer.
Sale of HSBC's North American Insurance Company Operations
In 2013, an Edwards Wildman team represented HSBC in its sale of its North American insurance company.
Edwards Wildman Team Advises Sole Shareholder in Sale of Stock
An Edwards Wildman team of attorneys advised the sole shareholder of Micronics, Inc., a New Hampshire, USA- and Stoke-on-Trent, England-based manufacturer of filtration products and equipment used in mining, water treatment and food and beverage industries, in a March 28, 2013 sale of his stock to an entity formed by Vance Street Capital, a Los Angeles-based private equity firm.
Acquisition and Combination of CoreLab Partners, Inc. and BioClinica, Inc.
A team of lawyers at Edwards Wildman represented Ampersand Capital Partners and SV Life Sciences in the investment in membership interests used, in part, to fund the acquisition of CoreLab Partners, Inc. and BioClinica, Inc.
CoreLab Partners Cash-Out Merger with BioClinica
Our Business Law lawyers represented CoreLab Partners, Inc. in its sale structured as a strategic cash-out merger to BioClinica.
Advised Modified Polymer Components, Inc. in a Strategic Merger with Biomedical Structures, LLC
A team of Edwards Wildman lawyers advised Modified Polymer Components, Inc. in a strategic merger with Biomedical Structures, LLC.
Applied Physical Sciences Stock Purchase
In December 2012 a team of Edwards Wildman Business Law lawyers represented Applied Physical Sciences Corp. in a stock purchase by General Dynamics.
Sale of Recombinant Data Corp. to Deloitte Consulting
Our lawyers represented Newton, Massachusetts - based Recombinant Data Corp. in the sale of its assets to Deloitte Consulting LLP and its post-closing liquidation.
PTC Stock Purchase of 4C Solutions
Our lawyers represented PTC in the stock purchase of 4C Solutions, a provider of warranty software solutions.
Edwards Wildman Client Advisory: Massachusetts Noncompete Provisions: A Thing of the Past?
April 2014 publication
Drafting & Negotiating Joint Venture, Licensing, Co-Development, Marketing & Distribution Agreements
February 26, 2014 event
MIT Enterprise Forum GET SMART
October 2, 2013 event
Edwards Wildman Client Advisory - Delaware Chancery Court Rules that a Reverse Triangular Merger Does Not Trigger Consent Requirement Under Non-Assignment Provision
April 2013 publication
Edwards Wildman Sponsors LabCentral, First Large Scale Biotech-Capable Shared Lab Facility in Cambridge, Mass.
August 8, 2013
Edwards Wildman Advises CoreLabs and Ampersand Capital Partners in Two-Step Acquisition, Reports The Deal
January 31, 2013
Edwards Wildman Advises Armour Group in Largest Insurance Runoff Transaction of the Year
October 25, 2012
In Computer Magazine Podcast and Article, Greg Ploussios Reviews Legal Issues in Open Source Software
June 26, 2012
Firm Launches HIT Program
February 1, 2010
EAPD Success on Behalf of Aetna
July 31, 2009